Direct Filing of Valsartan Cases into the MDL Granted

Introduction

U.S. District Judge Robert B. Kugler, presiding over all federal valsartan recall lawsuits, allowed the direct filing of new cases into the multidistrict litigation(MDL) established in New Jersey, where all similar claims are consolidated for pretrial proceedings.

Judge Kugler issued a case management order on April 9, in which the process for the direct filing was outlined. There are nearly 50 product liability lawsuits filed against generic valsartan drug manufacturers and distributors, each with similar claims that the blood pressure drug distributed all these years were tainted with cancer-causing impurities, including N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), which are supposedly by-products of the drug's manufacturing process.

Comments

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Direct Filing of Valsartan Cases into the MDL Granted